Bank Of Montreal Bio N Tech Se Transaction History

Bank Of Montreal

$197 Billion
Q2 2024

A detailed history of Bank Of Montreal transactions in Bio N Tech Se stock. As of the latest transaction made, Bank Of Montreal holds 13,226 shares of BNTX stock, worth $1.43 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,226

Previous 14,325 7.67%

Holding current value

$1.43 Million

Previous $1.32 Million 19.61%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$80.36 - $102.87 $88,315 - $113,054	-1,099 Reduced 7.67%	13,226 $1.06 Million
Q1 2024 May 13, 2024	BUY	$88.96 - $112.35 $106,396 - $134,370	1,196 Added 9.11%	14,325 $1.32 Million
Q4 2023 Feb 08, 2024	BUY	$90.91 - $112.75 $1.19 Million - $1.48 Million	13,129 New	13,129 $1.39 Million
Q2 2023 Aug 02, 2023	SELL	$102.58 - $129.66 $2.66 Million - $3.36 Million	-25,925 Reduced 74.91%	8,681 $936,000
Q1 2023 Jun 13, 2024	SELL	$122.57 - $153.67 $1.46 Million - $1.83 Million	-11,924 Reduced 83.24%	2,401 $299,000
Q4 2022 Feb 01, 2023	SELL	$118.43 - $186.05 $1.9 Million - $2.99 Million	-16,058 Reduced 31.7%	34,606 $5.2 Million
Q3 2022 Nov 10, 2022	SELL	$127.65 - $183.11 $32,933 - $47,242	-258 Reduced 0.51%	50,664 $6.88 Million
Q2 2022 Aug 11, 2022	SELL	$123.25 - $186.24 $9.49 Million - $14.3 Million	-76,984 Reduced 60.19%	50,922 $7.25 Million
Q1 2022 May 12, 2022	BUY	$126.25 - $231.85 $12.6 Million - $23.2 Million	100,177 Added 361.27%	127,906 $23.3 Million
Q4 2021 Feb 11, 2022	SELL	$216.64 - $362.52 $5.91 Million - $9.89 Million	-27,287 Reduced 49.6%	27,729 $7.13 Million
Q3 2021 Nov 12, 2021	BUY	$205.93 - $447.23 $2.69 Million - $5.84 Million	13,060 Added 31.13%	55,016 $15.4 Million
Q2 2021 Aug 12, 2021	BUY	$113.32 - $241.49 $4.75 Million - $10.1 Million	41,956 New	41,956 $9.75 Million

Others Institutions Holding BNTX

# of Institutions

323

Shares Held

38.9M

Call Options Held

845K

Put Options Held

1.28M

View Full List

About BioNTech SE

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $26.2B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

More about BNTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.

Account